Voluven

Product manufactured by Hospira Inc.

Application Nr Approved Date Route Status External Links
BN070012 1985-06-12 Intravenous DISCN Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage VoluvenĀ® (6% Hydroxyethyl Starch 130/0.4 In 0.9% Sodium Chloride Injection) Is Indicated For The Treatment And Prophylaxis Of Hypovolemia In Adults And Children. It Is Not A Substitute For Red Blood Cells Or Coagulation Factors In Plasma. VoluvenĀ® Is A Plasma Volume Substitute Indicated For The Treatment And Prophylaxis Of Hypovolemia In Adults And Children. (1)

All Formulated Excipients (1 Total)

Name Structure Kind Function Status
1. Sodium Hydroxide SODIUM HYDROXIDE Unresolved BC-Boiler compound , B&N-Buffer & neutralizing agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Hydroxyethyl Starch 130/0.4

Comments